Ibex Medical Analytics, a pioneer in artificial intelligence (AI)-based cancer diagnostics, and
KSM, the Research and Innovation Center of Maccabi Healthcare Services – Israel s leading HMO - announced today a first-of-a-kind pilot of Ibex s Galen Breast solution for AI-powered primary diagnosis of breast cancer at Maccabi s Pathology Institute.
Breast cancer is the most common malignant disease in women worldwide, with over 2 million new cases each year. Early and accurate detection is critical for effective treatment and saving women s lives.
Maccabi KSM Logo
The pilot at Maccabi s Pathology Institute includes 2,000 breast biopsies on which pathologists will use Galen Breast as a First Read application. It is the first-ever deployment of an AI application for primary diagnosis of breast cancer.
Ibex Medical Analytics, a pioneer in artificial intelligence (AI)-based cancer diagnostics, and
KSM, the Research and Innovation Center of Maccabi Healthcare Services – Israel s leading HMO - announced today a first-of-a-kind pilot of Ibex s Galen Breast solution for AI-powered primary diagnosis of breast cancer at Maccabi s Pathology Institute.
Breast cancer is the most common malignant disease in women worldwide, with over 2 million new cases each year. Early and accurate detection is critical for effective treatment and saving women s lives.
Maccabi KSM Logo
The pilot at Maccabi s Pathology Institute includes 2,000 breast biopsies on which pathologists will use Galen Breast as a First Read application. It is the first-ever deployment of an AI application for primary diagnosis of breast cancer.